A mutation of the interaction partner nucleophosmin (NPM), a highly prominent mutation in normal karyotype AML [148], results in the loss of interaction between NCL and NPM in vitro [149]. The gene discussed is NUCLEOLIN; the disease is acute myeloid leukemia.